Of significance, MDK expression was detected in 83% of patients with early-stage AFP-negative HCC, leading to the observation that MDK detection is a powerful supplement to AFP detection for the diagnosis of HCC, especially in early-stage and AFP-negative HCC. The gene discussed is MDK; the disease is hepatocellular carcinoma.